Mallika Dhawan
Hematology & Oncology · San Francisco, CANPI 1225320310
Payments from drug & device makers
Across 55 payments — averaging $8559.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$378K
- Pfizer$51K
- Genentech, Inc.$42K
Across 2 payments — averaging $1420.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 52 | $377,986 |
| Pfizer | 1 | $50,750 |
| Genentech, Inc. | 2 | $42,029 |
How this compares
$470,765 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in San Francisco
- Alain AlgaziSan Francisco$119.2M
- Pamela MunsterSan Francisco$13.7M
- Collin BlakelySan Francisco$8.8M
- Terence FriedlanderSan Francisco$3.8M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.